Ad is loading...
JIGRX
Price
$45.32
Change
-$0.44 (-0.96%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

JIGRX vs VTSNX

Header iconJIGRX vs VTSNX Comparison
Open Charts JIGRX vs VTSNXBanner chart's image
Janus Henderson Overseas S
Price$45.32
Change-$0.44 (-0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
JIGRX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JIGRX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIGRX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. JIGRX (3.38B). VTSNX pays higher dividends than JIGRX: VTSNX (3.29) vs JIGRX (0.97). JIGRX was incepted earlier than VTSNX: JIGRX (15 years) vs VTSNX (14 years). JIGRX is a more actively managed with annual turnover of: 42.00 vs. VTSNX (4.00). JIGRX has a lower initial minimum investment than VTSNX: JIGRX (2500) vs VTSNX (5000000). JIGRX (11.40) and VTSNX (10.92) have marching annual gain over last year. JIGRX return over 5 years is better than : 45.46 vs. VTSNX (15.91).
JIGRXVTSNXJIGRX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years14 years-
Gain YTD4.5444.535100%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.38B442B1%
Annual Yield % from dividends0.973.2930%
Returns for 1 year11.4010.92104%
Returns for 3 years3.75-5.86-64%
Returns for 5 years45.4615.91286%
Returns for 10 years50.6329.81170%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals